Jaguars cornerback/wide receiver Travis Hunter is not yet fully cleared to return from last year’s season-ending knee injury, but he’s getting there. That’s the word from Jaguars General Manager James ...

At a time when minority owner Tom Brady’s role with the Raiders isn’t clear, he gave a clear indication as to his current level of involvement. Via Ryan McFadden of ESPN, Brady was in the building for ...

In a game of chess two states go to war, the pawns dying to save the king. In mancala, a board game popular in Africa, all pieces are alike, and players try to win them over. That shows how societies ...

War in the Middle East may be roiling markets and testing global stability, but one priority endures for Vladimir Putin’s Russia: rewriting history. Last week, the state-backed Russian ...

The Trump administration plans to require banks to collect citizenship data from account holders. The proposed executive order could cost banks billions and add millions of hours of paperwork. The ...

With new limits on federal lending, many students will need private loans and some could be shut out. See the data, program by program. By Amy Fan Amy Fan spoke with university employees, former ...

“Affordability” is a central theme for Democrats in this year’s midterm elections, which makes good sense. Julie Z. Weil called it “the political word of the moment.” It addresses the ”economic ...

DARIO, DEMIS, Elon, Mark and Sam. The five most important people in artificial intelligence are so famous that first names alone are enough to identify them. Politicians and journalists hang on their ...

Epidemiological evidence suggests that an adverse prenatal environment permanently 'programs' physiology and increases the risk of cardiovascular, metabolic, neuroendocrine and psychiatric disorders ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

May 4, 2026 Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review ...